AgomAb Therapeutics NV

AGMB

Healthcare Biotechnology

7.64 0.67 +9.61%
Market cap
$376.0M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
0.00%
Net debt / EBITDA
2.0×
Dividend safety
n/a
Jun '26 Dec '25 Sep '25 Dec '24
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
0.00 — — —
Free Cash Flow
(144.00) — — —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026